508-75-8
Chemical Structure
Convallatoxin
- CAS No.: 508-75-8
- Formula:C29H42O10
- Molecular Weight:550.64
IUPAC Name: (3S,5S,8R,9S,10S,13R,14S,17R)-5,14-dihydroxy-13-methyl-17-(5-oxo-2,5-dihydrofuran-3-yl)-3-(((2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)hexadecahydro-10H-cyclopenta[a]phenanthrene-10-carbaldehyde
InChIKey: HULMNSIAKWANQO-JQKSAQOKSA-N
SMILES: O=C1OCC([C@H]2CC[C@]3(O)[C@]4([H])CC[C@]5(O)C[C@@H](O[C@H]6[C@@H]([C@@H]([C@H]([C@H](C)O6)O)O)O)CC[C@]5(C=O)[C@@]4([H])CC[C@]23C)=C1
Biological Activity: Convallatoxin is a cardiac glycoside isolated from Adonis amurensis Regel et Radde. Convallatoxin ameliorates colitic inflammation via activation of PPARγ and suppression of NF-κB. Convallatoxin is a P-glycoprotein (P-gp) substrate and recognized Val982 as an important amino acid involved in its transport. Convallatoxin is an enhancer of ligand-induced MOR endocytosis with high potency and efficacy. Anti-inflammatory and anti-proliferative properties[1][2][3].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Convallatoxin | 99.72% | Convallatoxin is a cardiac glycoside isolated from Adonis amurensis Regel et Radde. Convallatoxin ameliorates colitic inflammation via activation of PPARγ and suppression of NF-κB. Convallatoxin is a P-glycoprotein (P-gp) substrate and recognized Val982 as an important amino acid involved in its transport. Convallatoxin is an enhancer of ligand-induced MOR endocytosis with high potency and efficacy. Anti-inflammatory and anti-proliferative properties. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Convallatoxin (Standard) | ≥98% | Convallatoxin (Standard) is the analytical standard of Convallatoxin. This product is intended for research and analytical applications. Convallatoxin is a cardiac glycoside isolated from Adonis amurensis Regel et Radde. Convallatoxin ameliorates colitic inflammation via activation of PPARγ and suppression of NF-κB. Convallatoxin is a P-glycoprotein (P-gp) substrate and recognized Val982 as an important amino acid involved in its transport. Convallatoxin is an enhancer of ligand-induced MOR endocytosis with high potency and efficacy. Anti-inflammatory and anti-proliferative properties. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Peruvoside | 99.32% | Peruvoside is a potent inhibitor of Src, PI3K, JNK, STAT, and EGFR. Peruvoside induces apoptosis and autophagy and possesses a broad spectrum of anticancer activity in breast, lung, liver cancers and leukemia. Peruvoside is a broad-spectrum and potent antiviral activity against positive-sense RNA viruses. Peruvoside sensitizes Gefitinib (HY-50895)-resistant tumour cells (A549, PC9/gef and H1975) to Gefitinib. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Cymarin | 97.28% | Cymarin, a cardiac glycoside, potently inhibits the Palytoxin (PTX)-induced K+ release (IC50=0.42 μM). Cymarin reveals an antitumor activity against breast cancer and pancreatic cancer. Cymarin exhibits antifeedant and growth inhibitory effects as crop protectant. |
||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Cuspidoside | Cuspidoside is a cardiac glycoside and can be used for the research of cardiovascular disease, such as heart failure. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Helveticoside | 95.99% | Helveticoside (Strophanthidin-digitoxoside) is a helveticosid, possesses an ED50 of 0.17 μM for isolated guinea-pig ileum. Helveticoside has anticancer effect. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Digitoxigenin-3-O-β-D-quinovoside | Digitoxigenin-3-O-β-D-quinovoside is an interleukin-2 (IL-2)/luciferase inhibitor with an IC50 value of 52 nM. Digitoxigenin-3-O-β-D-quinovoside is a cardiac lactone isolated from Elaeodendron australe var. integrifolium. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Odoroside | Odoroside (Solanoside) is a cardiac glycoside present in oleander (Nerium oleander L). | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Acolongifloroside K | Acolongifloroside K is a cardenolide toxin identified from the seeds of Strophanthus gratus. It exhibits acute cardiotoxicity, with acute toxicity comparable to that of Ouabain (HY-B1457). Acolongifloroside K is an active component in Maasai arrow poison prepared from Acokanthera schimperi. Acolongifloroside K can be used in studies related to cardiotoxicity and cardenolides. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Periplocymarin | 99.90% | Periplocymarin, a cardiac glycoside isolated from Periploca sepium and Periploca graeca, is a potential anti-cancer compound. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Evomonoside | Evomonoside is a type of cardiac glycoside compound. Evomonoside exhibits significant in vitro anticancer activity, especially having nanomolar inhibitory concentrations against gastric cancer cell lines. Evomonoside has typical cardiac toxicity risks, including arrhythmias and conduction abnormalities. Evomonoside can be used for research on gastric cancer. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
- [1]. Li MY, et al. Convallatoxin protects against dextran sulfate sodium-induced experimental colitis in mice by inhibiting NF-κB signaling through activation of PPARγ. Pharmacol Res. 2019 Sep;147:104355. [Content Brief]
- [2]. Gozalpour E, et al. Convallatoxin: a new P-glycoprotein substrate. Eur J Pharmacol. 2014 Dec 5;744:18-27. [Content Brief]
- [3]. Chao PK, et al. Convallatoxin enhance the ligand-induced mu-opioid receptor endocytosis and attenuate morphine antinociceptive tolerance in mice. Sci Rep. 2019 Feb 20;9(1):2405. [Content Brief]